Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis

HW Zimmermann, F Tacke - Inflammation & Allergy-Drug …, 2011 - ingentaconnect.com
Despite increasing knowledge about molecular pathways in pathogenesis of chronic liver
disease, selective therapeutic options are scarce, especially in advanced diseases …
被引用次数：168 相关文章

[引用][C] Modification of Chemokine Pathways and Immune Cell Infiltration as a Novel Therapeutic Approach in Liver Inflammation and Fibrosis

HW Zimmermann, F Tacke - Inflammation & Allergy-Drug Targets, 2011 - cir.nii.ac.jp
Modification of Chemokine Pathways and Immune Cell Infiltration as a Novel Therapeutic
Approach in Liver Inflammation and Fibrosis | CiNii Research CiNii 国立情報学研究所 学術情報 …

Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis.

HW Zimmermann, F Tacke - Inflammation & Allergy Drug Targets, 2011 - europepmc.org
Despite increasing knowledge about molecular pathways in pathogenesis of chronic liver
disease, selective therapeutic options are scarce, especially in advanced diseases …

Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis

HW Zimmermann, F Tacke - Inflammation & allergy drug …, 2011 - pubmed.ncbi.nlm.nih.gov
Despite increasing knowledge about molecular pathways in pathogenesis of chronic liver
disease, selective therapeutic options are scarce, especially in advanced diseases …